In cisplatin-resistant LC cells, lncRNA ZXF1 contributes to cisplatin resistance and leads to the poor prognosis of LC patients by activating MAPK pathway and MMP 2/9 (52). Here, ACTA2-AS1 is linked to laryngotracheoesophageal cleft.